NCF International

EMA has published a new Q&A guideline focused on GMP and quality aspects related to 3D printing in pharmaceutical manufacturing. The document applies to human and veterinary medicines as well as investigational products

Artificial Intelligence (AI) and Machine Learning (ML) are playing an increasingly central role in pharmaceutical manufacturing and control. A position paper published by IFPMA in March 2026 outlines both the opportunities and the challenges associated with their adoption across the sector

Investment in innovative medicines should be regarded not merely as a healthcare expenditure but as a driver of substantial social and economic value. This is the key finding of EFPIA’s latest comprehensive study on the value of pharmaceutical innovation, published in June 2026

The first report on the state of clinical trials in Europe, published jointly by the European Commission, HMA, and EMA, provides an overview of active clinical trials in the first quarter of 2026 and compares current performance with the objectives established under the Accelerating Clinical Trials in the EU (ACT EU) initiative